Products
Platform
Research
Market
Learn
Novelix Pharmaceuticals Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 1.30 | 1.42 | 0.78 | 1.18 | 2.76 |
| Other Income Qtr Cr | 0.06 | 0.06 | 0.09 | 0.07 | 0.30 |
| Operating Revenues Qtr | 1.24 | 1.36 | 0.69 | 1.11 | 2.46 |
Loading chart... | |||||
Operating Expenses Qtr | 1.42 | 1.51 | 2.32 | 2.04 | 2.31 |
Operating Profit Qtr | -0.18 | -0.15 | -1.63 | -0.93 | 0.15 |
EBITDA Qtr Cr | -0.12 | -0.09 | -1.54 | -0.86 | 0.47 |
Depreciation Qtr | 0.02 | 0.02 | -0.03 | 0.04 | 0.04 |
Net Profit Qtr | -0.15 | -0.07 | -1.35 | -0.74 | 0.35 |
Basic EPS Qtr | -0.19 | -0.11 | -1.67 | -0.77 | 0.39 |
Open Demat Account
Open Demat Account